Social Security chief orders broad review of benefit overpayments

The federal agency that oversees Social Security announced today that it will review the way it handles “overpayments” – money it sends beneficiaries that it later determines they weren’t entitled to receive.

Calls for humanitarian pause to safeguard polio vaccination efforts in Gaza

Two rounds of a polio vaccination campaign are expected to be launched at the end of August and September 2024 across the Gaza Strip to

August 18, 2024

Revolution Medicines to buy biopharmaceutical firm EQRx

The transaction aims to strengthen Revolution’s parallel development approach to its RAS(ON) inhibitor pipeline in multiple RAS-driven cancers. Credit: Meletios Verras / Shutterstock.com. Revolution Medicines

August 2, 2023

Editas tacks again, steering from lead sickle cell treatment to new one

Editas Medicine said Tuesday it will license out or partner its lead sickle cell treatment, the latest shift for a tarantella company that has repeatedly

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.